BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25693938)

  • 1. The relationship between P16 gene promoter methylation and gastric cancer: a meta-analysis based on Chinese patients.
    Peng D; Zhang H; Sun G
    J Cancer Res Ther; 2014 Dec; 10 Suppl():292-5. PubMed ID: 25693938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis of serum p16 gene promoter methylation for diagnosis of nonsmall cell lung cancer.
    Yan R; Chi L; Zheng X; Sun R; You J; Ye X
    Indian J Cancer; 2015 Dec; 52 Suppl 2():e116-8. PubMed ID: 26728668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P16
    Tuo L; Sha S; Huayu Z; Du K
    Thorac Cancer; 2018 Aug; 9(8):1032-1040. PubMed ID: 29927090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of p16 gene promoter methylation in gastric carcinogenesis: a meta-analysis.
    Wang HL; Zhou PY; Liu P; Zhang Y
    Mol Biol Rep; 2014 Jul; 41(7):4481-92. PubMed ID: 24610350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APC gene promoter methylation as a potential biomarker for lung cancer diagnosis: A meta-analysis.
    Liu F; Lu X; Zhou X; Huang H
    Thorac Cancer; 2021 Nov; 12(21):2907-2913. PubMed ID: 34545707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association Between MGMT Promoter Methylation and Patients with Gastric Cancer: A Meta-Analysis.
    Yuan X; Xu J; Fang W; Zhao Z; Wang F; Tong Z
    Genet Test Mol Biomarkers; 2017 Apr; 21(4):213-221. PubMed ID: 28384044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchial lavage P 16INK4A gene promoter methylation and lung cancer diagnosis: A meta-analysis.
    Yifan D; Qun L; Yingshuang H; Xulin L; Jianjun W; Qian M; Yuman Y; Zhaoyang R
    Indian J Cancer; 2015 Dec; 52 Suppl 2():e96-8. PubMed ID: 26728683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Value of MicroRNA-18a for Gastric Cancer: a Meta-Analysis.
    Liang Q; Zhang G; Wang J; Sheng S
    Clin Lab; 2018 Jan; 64(1):177-184. PubMed ID: 29479894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between p16 gene promoter methylation and clinicopathologic features of colorectal cancer: a meta-analysis of 27 cohort studies.
    Chen YZ; Liu D; Zhao YX; Wang HT; Gao Y; Chen Y
    DNA Cell Biol; 2014 Oct; 33(10):729-38. PubMed ID: 24979649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of APC gene promoter methylation and the risk of gastric cancer: A meta-analysis and bioinformatics study.
    Zhou X; Jiao D; Dou M; Zhang W; Hua H; Chen J; Li Z; Li L; Han X
    Medicine (Baltimore); 2020 Apr; 99(16):e19828. PubMed ID: 32312003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant promoter hypermethylation of p16, survivin, and retinoblastoma in gastric cancer.
    Guo L; Huang C; Ji QJ
    Bratisl Lek Listy; 2017; 118(3):164-168. PubMed ID: 28319413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P16 gene promoter methylation is associated with oncogenesis and progression of gastric carcinomas: A systematic review and meta-analysis.
    Spagnol LW; Polettini J; Silveira DA; Wegner GRM; Paiva DFF
    Crit Rev Oncol Hematol; 2022 Dec; 180():103843. PubMed ID: 36270449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between p16 Promoter Methylation and Thyroid Cancer Risk: A Meta-analysis.
    Wu W; Yang SF; Liu FF; Zhang JH
    Asian Pac J Cancer Prev; 2015; 16(16):7111-5. PubMed ID: 26514498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population.
    Chen X; Yang Y; Liu J; Li B; Xu Y; Li C; Xu Q; Liu G; Chen Y; Ying J; Duan S
    Oncotarget; 2017 Jan; 8(5):8105-8119. PubMed ID: 28042954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MGMT gene promoter methylation in humoral tissue as biomarker for lung cancer diagnosis: An update meta-analysis.
    Chen B; Ying X; Bao L
    Thorac Cancer; 2021 Dec; 12(23):3194-3200. PubMed ID: 34651448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis.
    Cui C; Sun X; Zhang J; Han D; Gu J
    J Cancer Res Ther; 2014 Nov; 10 Suppl():C131-4. PubMed ID: 25450270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma.
    Hu SL; Kong XY; Cheng ZD; Sun YB; Shen G; Xu WP; Wu L; Xu XC; Jiang XD; Huang DB
    Tumori; 2010; 96(5):726-33. PubMed ID: 21302620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic Silencing of the MLH1 Promoter in Relation to the Development of Gastric Cancer and its use as a Biomarker for Patients with Microsatellite Instability: a Systematic Analysis.
    Hu G; Qin L; Zhang X; Ye G; Huang T
    Cell Physiol Biochem; 2018; 45(1):148-162. PubMed ID: 29334683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic Efficacy of SHOX2 Gene Hypermethylation for Lung Cancer: A Meta-Analysis].
    Liu Q; Wang S; Pei G; Yang Y; Huang Y
    Zhongguo Fei Ai Za Zhi; 2021 Jul; 24(7):490-496. PubMed ID: 34275516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer.
    Abbaszadegan MR; Moaven O; Sima HR; Ghafarzadegan K; A'rabi A; Forghani MN; Raziee HR; Mashhadinejad A; Jafarzadeh M; Esmaili-Shandiz E; Dadkhah E
    World J Gastroenterol; 2008 Apr; 14(13):2055-60. PubMed ID: 18395906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.